Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DFTX compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
XENE
Xenon Pharmaceuticals Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DFTX
Definium Therapeutics, Inc.
vs
XENE
Xenon Pharmaceuticals Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
DFTX: latest quarter not drawable. XENE: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DFTX, solid
XENE, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DFTX
0
None
Shared
0
No disclosed counterparties: DFTX.
Only XENE
2
NBIX
Neurocrine Biosciences
supplier
BHC
Bausch Health
supplier
Role chip = supplier or customer
Source: SEC EDGAR
DFTX
Definium Therapeutics, Inc.
Change
36.31
▼
−4.34%
· post 36.33
Mkt cap
$4.9B
Revenue
—
XENE
Xenon Pharmaceuticals Inc.
Change
37.42
▼
−0.32%
· post 37.86
Closed
Oct 30 '26
Mkt cap
$3.6B
Revenue
$8M
Q1 FY25
vs
Compare
Closed
Oct 30 '26
DFTX
Definium Therapeutics, Inc.
vs
XENE
Xenon Pharmaceuticals Inc.
36.31
▼
−4.34%
post 36.33
Price
37.42
▼
−0.32%
post 37.86
$4.9B
Mkt cap
$3.6B
—
Revenue
$8M
Q1 FY25
Change
Change
DFTX
36.31
▼
−4.34%
vs
XENE
37.42
▼
−0.32%
Closed
Oct 30 '26